← Back to Search

Artificial Disc Replacement

PRESTIGE LP™ Cervical Disc for Cervical Disc Degeneration

N/A
Waitlist Available
Research Sponsored by Medtronic Spinal and Biologics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, and 12 months
Awards & highlights

Study Summary

This trial will study how much metal is in the blood of people who got surgery with a certain kind of medical device. The data will be used to improve safety for people using this device in the future.

Eligible Conditions
  • Cervical Disc Degeneration
  • Myelopathy
  • Radiculopathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concentrations of Titanium, Vanadium, and Aluminum in the Blood Serum
Secondary outcome measures
Neck Pain and Arm Pain
Number of Participants Who Achieved NDI Success
Number of Participants Who Achieved Neurological Success
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PRESTIGE LPExperimental Treatment1 Intervention
Patients receive surgical treatment with the PRESTIGE LP™ Cervical Disc at two contiguous cervical levels from C3-C7.

Find a Location

Who is running the clinical trial?

Medtronic Spinal and BiologicsLead Sponsor
55 Previous Clinical Trials
10,563 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being taken on for this experimental program?

"Medtronic Spinal and Biologics is sponsoring this clinical trial, in order to obtain data from 30 participants who meet their inclusion criteria. The study sites are located at Kellogg M.D., Brain & Spine (Portland, Oregon) as well as Todd H. Lanman, M.D., INC.(Beverly Hills, California)."

Answered by AI

Are there any opportunities for patients to participate in this experiment at present?

"Affirmative, the information on clinicaltrials.gov suggests that this experiment is presently recruiting patients. The study was initially published on June 6th 2018 and has been refreshed as of July 29th 2022 with a goal to recruit 30 participants from 3 distinctive locations."

Answered by AI
~4 spots leftby Apr 2025